These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 4062892)

  • 1. Arginine residues are critical for the heparin-cofactor activity of antithrombin III.
    Jorgensen AM; Borders CL; Fish WW
    Biochem J; 1985 Oct; 231(1):59-63. PubMed ID: 4062892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The heparin binding site of human antithrombin III. Selective chemical modification at Lys114, Lys125, and Lys287 impairs its heparin cofactor activity.
    Liu CS; Chang JY
    J Biol Chem; 1987 Dec; 262(36):17356-61. PubMed ID: 3121595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence that arginine-129 and arginine-145 are located within the heparin binding site of human antithrombin III.
    Sun XJ; Chang JY
    Biochemistry; 1990 Sep; 29(38):8957-62. PubMed ID: 2271571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-function relationships in heparin cofactor II: chemical modification of arginine and tryptophan and demonstration of a two-domain structure.
    Church FC; Villanueva GB; Griffith MJ
    Arch Biochem Biophys; 1986 Apr; 246(1):175-84. PubMed ID: 3754413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of arginine 132 and lysine 133 in heparin binding to and activation of antithrombin.
    Meagher JL; Huntington JA; Fan B; Gettins PG
    J Biol Chem; 1996 Nov; 271(46):29353-8. PubMed ID: 8910598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pyridoxylation of essential lysines in the heparin-binding site of antithrombin III.
    Pecon JM; Blackburn MN
    J Biol Chem; 1984 Jan; 259(2):935-8. PubMed ID: 6420409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The heparin-binding site of antithrombin III. Identification of a critical tryptophan in the amino acid sequence.
    Blackburn MN; Smith RL; Carson J; Sibley CC
    J Biol Chem; 1984 Jan; 259(2):939-41. PubMed ID: 6693405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probing the heparin-binding domain of human antithrombin III with V8 protease.
    Liu CS; Chang JY
    Eur J Biochem; 1987 Sep; 167(2):247-52. PubMed ID: 3305015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lysine-heparin interactions in antithrombin. Properties of K125M and K290M,K294M,K297M variants.
    Fan B; Turko IV; Gettins PG
    Biochemistry; 1994 Nov; 33(47):14156-61. PubMed ID: 7947827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of antithrombin III and thrombin-antithrombin III complex with cultured aortic endothelial cells.
    Bartha K; Kovács T; Léránt I; Papp B; Csonka E; Kolev K; Machovich R
    Thromb Res; 1987 Sep; 47(5):541-52. PubMed ID: 3672436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of individual carbohydrate chains of recombinant antithrombin on heparin affinity and on the generation of glycoforms differing in heparin affinity.
    Olson ST; Frances-Chmura AM; Swanson R; Björk I; Zettlmeissl G
    Arch Biochem Biophys; 1997 May; 341(2):212-21. PubMed ID: 9169007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparin-dependent modification of the reactive center arginine of antithrombin and consequent increase in heparin binding affinity.
    Pike RN; Potempa J; Skinner R; Fitton HL; McGraw WT; Travis J; Owen M; Jin L; Carrell RW
    J Biol Chem; 1997 Aug; 272(32):19652-5. PubMed ID: 9242619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding of heparin to human antithrombin III activates selective chemical modification at lysine 236. Lys-107, Lys-125, and Lys-136 are situated within the heparin-binding site of antithrombin III.
    Chang JY
    J Biol Chem; 1989 Feb; 264(6):3111-5. PubMed ID: 2492530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Important role of arginine 129 in heparin-binding site of antithrombin III. Identification of a novel mutation arginine 129 to glutamine.
    Gandrille S; Aiach M; Lane DA; Vidaud D; Molho-Sabatier P; Caso R; de Moerloose P; Fiessinger JN; Clauser E
    J Biol Chem; 1990 Nov; 265(31):18997-9001. PubMed ID: 2229057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a lysyl residue in antithrombin which is essential for heparin binding.
    Peterson CB; Noyes CM; Pecon JM; Church FC; Blackburn MN
    J Biol Chem; 1987 Jun; 262(17):8061-5. PubMed ID: 3110143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory mechanism of serpins. Identification of steps involving the active-site serine residue of the protease.
    Stone SR; Le Bonniec BF
    J Mol Biol; 1997 Jan; 265(3):344-62. PubMed ID: 9018048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Refolding properties of antithrombin III. Mechanism of binding to heparin.
    Villanueva GB; Allen N
    J Biol Chem; 1983 Nov; 258(22):14048-53. PubMed ID: 6643466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictions of the secondary structure of antithrombin III and the location of the heparin-binding site.
    Villanueva GB
    J Biol Chem; 1984 Feb; 259(4):2531-6. PubMed ID: 6698980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the domain structure of antithrombin III. Tentative localization of the heparin binding region using 1H NMR spectroscopy.
    Gettins P; Wooten EW
    Biochemistry; 1987 Jul; 26(14):4403-8. PubMed ID: 3663595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antithrombin Glasgow, 393 Arg to His: a P1 reactive site variant with increased heparin affinity but no thrombin inhibitory activity.
    Owen MC; Beresford CH; Carrell RW
    FEBS Lett; 1988 Apr; 231(2):317-20. PubMed ID: 3360140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.